|
DR1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.223600E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.676450E-02 |
| Normal-vs-Stage2 |
1.652580E-01 |
| Normal-vs-Stage3 |
9.69969999999876E-05 |
| Normal-vs-Stage4 |
2.448500E-04 |
| Stage1-vs-Stage2 |
9.557400E-01 |
| Stage1-vs-Stage3 |
2.821900E-02 |
| Stage1-vs-Stage4 |
6.643500E-02 |
| Stage2-vs-Stage3 |
2.315200E-01 |
| Stage2-vs-Stage4 |
2.717600E-01 |
| Stage3-vs-Stage4 |
8.963400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.767800E-04 |
| Normal-vs-AfricanAmerican |
9.98469999999863E-05 |
| Normal-vs-Asian |
7.760600E-01 |
| Caucasian-vs-AfricanAmerican |
6.520300E-02 |
| Caucasian-vs-Asian |
2.056000E-01 |
| AfricanAmerican-vs-Asian |
5.854000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.555600E-04 |
| Normal-vs-Female |
6.200800E-03 |
| Male-vs-Female |
6.301800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.135600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.582800E-03 |
| Normal-vs-Age(61-80Yrs) |
2.566900E-04 |
| Normal-vs-Age(81-100Yrs) |
5.617300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.147000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.730600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.487970E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.816600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.039020E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.748380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.927200E-01 |
| Normal-vs-Grade 2 |
6.779700E-02 |
| Normal-vs-Grade 3 |
1.57017999999898E-05 |
| Normal-vs-Grade 4 |
1.552530E-04 |
| Grade 1-vs-Grade 2 |
6.711200E-01 |
| Grade 1-vs-Grade 3 |
7.057600E-02 |
| Grade 1-vs-Grade 4 |
8.389800E-02 |
| Grade 2-vs-Grade 3 |
3.443700E-03 |
| Grade 2-vs-Grade 4 |
1.300330E-02 |
| Grade 3-vs-Grade 4 |
4.928600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.517770E-01 |
| Normal-vs-ccB subtype |
1.101420E-03 |
| ccA subtype-vs-ccB subtype |
2.173900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.664400E-03 |
| Normal-vs-N1 |
3.931700E-02 |
| N0-vs-N1 |
5.406000E-01 |
|
|
